
Repligen Corp
NASDAQ:RGEN

Intrinsic Value
The intrinsic value of one
RGEN
stock under the Base Case scenario is
70.85
USD.
Compared to the current market price of 118.15 USD,
Repligen Corp
is
Overvalued by 40%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Repligen Corp
Fundamental Analysis


Revenue & Expenses Breakdown
Repligen Corp
Balance Sheet Decomposition
Repligen Corp
Current Assets | 1B |
Cash & Short-Term Investments | 697.2m |
Receivables | 147.4m |
Other Current Assets | 187.8m |
Non-Current Assets | 1.8B |
PP&E | 325.2m |
Intangibles | 1.5B |
Other Non-Current Assets | 2.9m |
Free Cash Flow Analysis
Repligen Corp
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Repligen Corp
Revenue
|
803.6m
USD
|
Cost of Revenue
|
-393.6m
USD
|
Gross Profit
|
410m
USD
|
Operating Expenses
|
-389.4m
USD
|
Operating Income
|
20.6m
USD
|
Other Expenses
|
-40.3m
USD
|
Net Income
|
-19.7m
USD
|
RGEN Profitability Score
Profitability Due Diligence
Repligen Corp's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Score
Repligen Corp's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
RGEN Solvency Score
Solvency Due Diligence
Repligen Corp's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Score
Repligen Corp's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RGEN Price Targets Summary
Repligen Corp
According to Wall Street analysts, the average 1-year price target for
RGEN
is 187.27 USD
with a low forecast of 141.4 USD and a high forecast of 231 USD.
Dividends
Current shareholder yield for RGEN is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
RGEN
stock under the Base Case scenario is
70.85
USD.
Compared to the current market price of 118.15 USD,
Repligen Corp
is
Overvalued by 40%.